| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -3e-05 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 4.9e-05 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -3.4e-05 | 1 |